Hongming Song
- Cancer Research top 5%
- MicroRNA in disease regulation 17
- Cancer-related molecular mechanisms research 10
- Molecular Biology top 10%
- Circular RNAs in diseases 11
- RNA Research and Splicing 8
- RNA modifications and cancer 7
-
- Hippo pathway signaling and YAP/TAZ 4
-
- Cancer-related Molecular Pathways 4
-
- Cancer Mechanisms and Therapy 4
- Journals
- Frontiers in Plant Science (1 paper)RSC Advances (1 paper)Molecular & Cellular Proteomics (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hongming Song
37 papers receiving 990 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 617
- Molecular Biology 750
- Cell Biology 98
- Oncology 141
- Immunology 63
Countries citing papers authored by Hongming Song
This map shows the geographic impact of Hongming Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongming Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongming Song more than expected).
Fields of papers citing papers by Hongming Song
This network shows the impact of papers produced by Hongming Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongming Song. The network helps show where Hongming Song may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongming Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 8 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 31 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 17 | |
| 10 | 2020 | 19 | |
| 11 | 2020 | 17 | |
| 12 | 2019 | 35 | |
| 13 | 2017 | 39 | |
| 14 | 2017 | 37 | |
| 15 | 2017 | 31 | |
| 16 | 2016 | 69 | |
| 17 | 2015 | 26 | |
| 18 | 2015 | 27 | |
| 19 | Silencing of DUSP6 gene by RNAi-mediation inhibits proliferation and growth in MDA-MB-231 breast cancer cells: an in vitro study. | 2015 | 16 |
| 20 | 2014 | 70 |
About Hongming Song
Hongming Song is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Circular RNAs in diseases (11 papers), Cancer-related molecular mechanisms research (10 papers), RNA Research and Splicing (8 papers), RNA modifications and cancer (7 papers), Cancer Mechanisms and Therapy (4 papers), Hippo pathway signaling and YAP/TAZ (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (617 citations), Molecular Biology (750 citations) and Cell Biology (98 citations). Hongming Song has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lin Fang, Kaiyao Hua, Dengfeng Li, Jialu Song, Tianqi Wu, Chuankui Wei, Hui Xu, Jiashu Hu, Deng‐Feng Li and Dan Xie. Their work appears in journals such as Frontiers in Plant Science, RSC Advances and Molecular & Cellular Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.